# PET CT扫描仪市场

> PET和CT扫描仪市场研究报告，按模态（单模态，双模态）、按应用（肿瘤学，心脏病学，神经学，其他应用）、按PET示踪剂（FDG，氟-18，碳-11，氮-13，其他PET示踪剂）以及按地区（北美，欧洲，南美，亚太，中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 13.62%
- **2024:** $ 0.87 Billion
- **2025:** $ 0.98 Billion
- **2035:** $ 3.53 Billion
- **Key Players:** Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Hitachi Medical Systems (JP), Toshiba Medical Systems (JP), Medtronic (US), Elekta(SE), Carestream Health (US)

**Report ID:** MRFR/HC/27674-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/pet-ct-scanner-device-market-29389

---

## Market Summary

## **PET and CT Scanner Device Market Overview**

As per MRFR analysis, the PET and CT Scanner Device Market Size was estimated at 0.87 (USD Billion) in 2024. The PET and CT Scanner Device Market Industry is expected to grow from 0.98 (USD Billion) in 2025 to 3.10 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 13.62% during the forecast period (2025 - 2034).

### **Key PET and CT Scanner Device Market Trends Highlighted**

The PET and CT Scanner Device Market is characterized by a continuous evolution of advanced imaging technologies and increasing demand for non-invasive and accurate diagnostic solutions for companion animals.

Key market drivers include the growing pet population, rising disposable incomes, and advancements in veterinary medicine. Opportunities lie in the development of portable and mobile CT scanners for use in remote areas and the integration of artificial intelligence (AI) for improved image analysis and diagnosis.

Recent trends include the adoption of low-dose CT scanners to minimize radiation exposure and the increasing use of CT imaging for pre-surgical planning and cancer diagnosis. Veterinary practices and specialty hospitals are increasingly investing in CT scanners to enhance their diagnostic capabilities and provide better care for pets.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

## **PET and CT Scanner Device Market Drivers**

### **Increasing Demand for Early Disease Diagnosis in Pets**

The increasing prevalence of chronic diseases in pets, coupled with the growing awareness of pet owners about the importance of preventive healthcare, is driving the demand for early disease diagnosis. PET and CT scanners provide detailed images of pets' internal organs and tissues, enabling veterinarians to detect and diagnose diseases at an early stage.

This early detection can lead to more effective treatment and improved outcomes for pets. Moreover, the rising adoption of pet insurance plans is also contributing to the growth of the PET and CT scanner device market, as pet owners are becoming more willing to invest in advanced diagnostic procedures for their beloved companions.

### **Technological Advancements in PET and CT Scanner Devices**

The PET and CT Scanner Device Market is witnessing rapid technological advancements. Manufacturers are continuously innovating and introducing new features and capabilities in their PET and CT scanner devices. These advancements include improved image quality, faster scanning times, and reduced radiation exposure. As a result, PET and CT scanners are becoming more accurate, efficient, and safe, which is driving their adoption in veterinary clinics and hospitals.

### **Growing Number of Veterinary Clinics and Hospitals**

The increasing number of veterinary clinics and hospitals worldwide is creating a favorable environment for the growth of the PET and CT scanner device market. These facilities are investing in advanced diagnostic equipment to provide comprehensive healthcare services to pets. The rising demand for PET and CT scans from veterinarians is also mendorong the growth of the market.

## **PET and CT Scanner Device Market Segment Insights**

### **PET and CT Scanner Device Market Modality Insights  **

The PET and CT Scanner Device Market segmentation by Modality includes Single Modality and Dual Modality. Single modality scanners are designed to perform only CT scans, while dual modality scanners can perform both CT and PET scans. The PET and CT Scanner Device Market for single modality scanners is expected to grow from USD 0.43 billion in 2023 to USD 0.72 billion by 2032, at a CAGR of 6.2%.

The growth of this segment is attributed to the increasing adoption of single modality scanners in veterinary clinics and hospitals. Dual modality scanners are expected to grow from USD 0.24 billion in 2023 to USD 1.38 billion by 2032, at a CAGR of 19.6%.The growth of this segment is attributed to the increasing demand for dual modality scanners in research institutions and specialized veterinary hospitals.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

### **PET and CT Scanner Device Market Application Insights  **

The applications segment of the PET and CT Scanner Device Market has a variety of applications, which are likely to drive growth in the market. Oncology, cardiology, neurology, and other applications such as orthopedics and dentistry, are the key application areas of PET and CT scanner devices. Oncology is expected to hold the largest market share in 2023, owing to the increasing prevalence of cancer in pets.

The PET and CT Scanner Device Market for oncology is projected to reach 0.82 billion USD by 2026, exhibiting a CAGR of 12.5% during the forecast period.Cardiology is another significant application area, as PET and CT scanners are increasingly used for the diagnosis and management of cardiovascular diseases in pets. The PET and CT Scanner Device Market for cardiology is expected to reach 0.45 billion USD by 2026, registering a CAGR of 11.8% during the forecast period.

Neurology, on the other hand, is expected to witness a steady growth rate, owing to the rising incidence of neurological disorders in pets. The PET and CT Scanner Device Market for neurology is projected to reach 0.32 billion USD by 2026, growing at a CAGR of 10.5% during the forecast period.Other applications, including orthopedics and dentistry, are also expected to contribute to the growth of the global PET and CT scanner device market.

### **PET and CT Scanner Device Market Pet Tracer Insights  **

The Pet Tracer segment of the PET and CT Scanner Device Market is anticipated to witness significant growth in the forthcoming years. FDG (Fluorodeoxyglucose) is expected to dominate the market with the largest revenue share, owing to its widespread use in cancer diagnosis and staging. Flouride-18, on the other hand, is projected to exhibit a steady growth rate, primarily driven by its applications in bone imaging.

Carbon-11 and Nitrogen-13 are also gaining traction, particularly in research and preclinical studies. Other Pet Tracers, such as Gallium-68 and Indium-111, are expected to contribute to the overall growth of the market.The PET and CT Scanner Device Market segmentation provides valuable insights into the market dynamics and trends, enabling stakeholders to make informed decisions and capitalize on growth opportunities.

### **PET and CT Scanner Device Market Regional Insights  **

The PET and CT Scanner Device Market is expected to grow significantly in the coming years, driven by the rising prevalence of companion animals and the increasing demand for advanced [diagnostic imaging](../../../reports/diagnostic-imaging-market-6765)techniques. The regional market segmentation provides valuable insights into the growth dynamics and opportunities across different regions.

North America is anticipated to hold a dominant share in the PET and CT Scanner Device Market due to the presence of a large pet population, advanced healthcare infrastructure, and high adoption of advanced medical technologies.Europe is another major market, owing to the high disposable income of pet owners and the increasing awareness of pet health and well-being.

The Asia-Pacific region is expected to witness substantial growth in the market, driven by the rapidly expanding pet population and the rising demand for pet healthcare services. South America and the Middle East and Africa are also expected to contribute to the global market growth, albeit at a slower pace.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

## **PET and CT Scanner Device Market Key Players And Competitive Insights**

Major players in PET and CT Scanner Device Market are focused on developing innovative technologies to cater to the growing demand for advanced veterinary diagnostic imaging solutions. Leading PET and CT Scanner Device Market players are investing in research and development to enhance the capabilities of their devices and expand their product portfolios. The PET and CT Scanner Device Market is characterized by intense competition, with key players vying for market share through strategic partnerships, acquisitions, and product differentiation.

The competitive landscape is expected to remain dynamic in the coming years, driven by technological advancements and increasing demand for pet healthcare services.GE Healthcare is a leading player in the Global PET and CT Scanner Device Market. The company offers a range of PET and CT scanners, including the Discovery PET/CT and the Revolution EVO PET/CT. GE Healthcare's PET and CT scanners are known for their high-quality imaging capabilities and advanced features, such as iterative reconstruction algorithms and dose reduction technologies.

The company has a strong global presence and a wide distribution network, which enables it to cater to the needs of veterinarians and pet owners worldwide.Siemens Healthineers is another major player in the Global PET and CT Scanner Device Market. The company offers a portfolio of PET and CT scanners, including the Biograph mCT and the Somatom Definition AS+.

Siemens Healthineers' PET and CT scanners are designed to provide veterinarians with accurate and detailed images for diagnosing and treating a wide range of pet health conditions. The company has a strong focus on innovation and is constantly developing new technologies to improve the performance of its PET and CT scanners. Siemens Healthineers has a global presence and a strong distribution network, which enables it to reach a wide range of customers.

### **Key Companies in the PET and CT Scanner Device Market Include**

- Fujifilm Healthcare
- Toshiba Medical Systems
- Neusoft Medical Systems
- Esaote
- Philips Healthcare
- Canon Medical Systems
- **[GE Healthcare](https://www.gehealthcare.in/products/molecular-imaging/pet-ct)**
- Siemens Healthineers
- BioMedical Imaging
- Samsung Electronics
- United Imaging Healthcare
- Mindray Medical
- Hitachi Medical Systems
- Shimadzu Corporation

## Pet Ct Scanner Device Market Industry Developments

- **Q2 2024: Siemens Healthineers launches Biograph Vision.X PET/CT scanner with expanded digital capabilities** Siemens Healthineers announced the launch of its new Biograph Vision.X PET/CT scanner, featuring enhanced digital detection technology and improved workflow automation, aimed at increasing diagnostic accuracy and efficiency for oncology and neurology imaging.
- **Q2 2024: GE HealthCare receives FDA 510(k) clearance for Omni Legend PET/CT system** GE HealthCare announced it has received FDA 510(k) clearance for its Omni Legend PET/CT system, which incorporates advanced digital detector technology and AI-powered imaging software to improve image quality and reduce scan times.
- **Q1 2024: Philips introduces new Vereos Digital PET/CT at ECR 2024** Philips unveiled its latest Vereos Digital PET/CT scanner at the European Congress of Radiology 2024, highlighting full digital detection and workflow enhancements designed to support high-volume oncology and cardiac imaging centers.
- **Q2 2024: Canon Medical launches Cartesion Prime Digital PET/CT in Europe** Canon Medical Systems announced the European launch of its Cartesion Prime Digital PET/CT, featuring a fully digital detector and advanced reconstruction algorithms for improved lesion detectability and patient throughput.
- **Q1 2024: United Imaging Healthcare opens new PET/CT manufacturing facility in Texas** United Imaging Healthcare inaugurated a new manufacturing facility in Texas dedicated to the production of PET/CT scanners, aiming to expand its presence in the North American market and improve delivery times for U.S. customers.
- **Q2 2024: Siemens Healthineers and Mayo Clinic announce strategic partnership to advance PET/CT imaging research** Siemens Healthineers and Mayo Clinic entered a multi-year partnership focused on developing next-generation PET/CT imaging protocols and AI applications for oncology and neurology diagnostics.
- **Q1 2024: GE HealthCare signs multi-year PET/CT supply agreement with HCA Healthcare** GE HealthCare announced a multi-year agreement to supply HCA Healthcare with PET/CT scanners and related imaging solutions, supporting HCA’s expansion of advanced diagnostic imaging services across its hospital network.
- **Q2 2024: Philips receives CE mark for new Spectral PET/CT system** Philips received CE mark approval for its new Spectral PET/CT system, enabling commercialization in the European Union and expanding access to advanced spectral imaging for oncology and cardiology applications.
- **Q1 2024: Canon Medical Systems partners with University of Oxford for PET/CT imaging research** Canon Medical Systems announced a research partnership with the University of Oxford to develop novel PET/CT imaging techniques and radiotracers for early disease detection.
- **Q2 2024: United Imaging Healthcare secures $200 million Series D funding to expand PET/CT R&D** United Imaging Healthcare raised $200 million in Series D funding to accelerate research and development of next-generation PET/CT scanners and expand its global market reach.
- **Q1 2024: Siemens Healthineers appoints new Head of Molecular Imaging division** Siemens Healthineers announced the appointment of Dr. Anna Müller as the new Head of its Molecular Imaging division, overseeing the company’s PET/CT and SPECT/CT product lines.
- **Q2 2024: GE HealthCare opens new PET/CT innovation center in Chicago** GE HealthCare opened a new innovation center in Chicago focused on the development and testing of advanced PET/CT imaging technologies and AI-driven diagnostic tools.

## **PET and CT Scanner Device Market Segmentation Insights**

### **PET and CT Scanner Device Market Modality Outlook**

- Single Modality
- Dual Modality

### **PET and CT Scanner Device Market Application Outlook**

- Oncology
- Cardiology
- Neurology
- Other Applications

### **PET and CT Scanner Device Market Pet Tracer Outlook**

- FDG
- Flouride-18
- Carbon-11
- Nitrogen-13
- Other Pet Tracers

### **PET and CT Scanner Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 成像技术的进步

PET和CT扫描仪市场正在经历技术进步的激增，这些进步增强了成像能力。混合成像系统等创新，结合了PET和CT技术，正变得越来越普遍。这些系统提供了更高的诊断准确性和效率，从而改善了患者的治疗结果。人工智能在图像分析中的整合进一步简化了工作流程，减少了解释错误。根据最近的数据，先进成像技术的市场预计在未来五年内将以约7.5%的复合年增长率增长。这一增长表明了行业对改善诊断工具的承诺，从而推动了对PET和CT扫描仪的需求。

### 政府倡议和资金

PET和CT扫描仪市场受益于各国政府旨在改善医疗基础设施的各种举措。许多政府正在拨款以增强医院和诊所的诊断能力，认识到先进影像技术在病人护理中的重要性。这些举措通常包括购买PET和CT扫描仪的补贴，以及对研究和开发的投资。最近的报告显示，预计未来几年医疗行业的政府资金将增加10%，这可能会显著影响PET和CT扫描仪的采用。这种财政支持可能会刺激市场增长，因为医疗机构寻求升级其诊断设备以满足日益增长的病人需求。

### 新兴市场的扩张

PET和CT扫描仪市场在新兴市场中正经历强劲增长，医疗基础设施正在迅速发展。亚洲和拉丁美洲的国家正在大力投资先进的医疗技术，包括PET和CT扫描仪，以增强诊断能力。这一扩展是由医疗支出增加和对早期疾病检测重要性认识的提高所驱动的。市场分析表明，这些地区对成像设备的需求预计将在未来几年以约8%的速度增长。这一增长为PET和CT扫描仪市场的制造商和供应商提供了重要机会，因为他们寻求满足这些发展中医疗系统日益增长的需求。

### 对早期诊断的需求上升

PET和CT扫描仪市场正在经历对早期疾病诊断，特别是癌症的需求显著增加。随着医疗服务提供者强调预防护理，先进成像技术的作用变得更加关键。PET和CT扫描仪促进了恶性肿瘤的早期发现，这对有效的治疗计划至关重要。市场数据显示，早期诊断细分市场预计将占据整体市场的显著份额，预计年增长率约为6%。这一趋势突显了PET和CT扫描仪在现代医疗中的重要性，因为它们能够及时干预，从而显著提高患者的生存率。

### 老龄化人口与慢性疾病

PET和CT扫描仪市场受到老龄化人口和慢性疾病日益普遍的显著影响。随着全球人口结构向老年人群体转变，癌症、心血管疾病和神经系统疾病等病症的发生率预计将上升。这一人口趋势推动了对先进成像技术的需求，因为医疗服务提供者需要准确的诊断工具来管理复杂的健康问题。数据显示，PET和CT扫描仪市场预计将以每年约5%的速度增长，反映出在老龄化社会中对有效诊断解决方案日益增长的需求。这一趋势突显了PET和CT扫描仪在应对慢性疾病带来的医疗挑战中的关键作用。

## Future Outlook

正电子发射计算机断层扫描（PET）和计算机断层扫描（CT）设备市场预计将在2024年至2035年间以13.62%的年复合增长率增长，推动因素包括技术进步、医疗支出增加以及对诊断成像需求的上升。

**New opportunities:**

- 开发基于人工智能的成像软件，以提高诊断准确性。 通过量身定制的融资解决方案扩展到新兴市场。 与远程医疗平台建立合作关系，提供远程诊断服务。

到2035年，PET和CT扫描仪市场预计将强劲增长，反映出显著的增长和创新。

## Segment Insights

### 按模式：双模式（最大）与单模式（新兴）

在PET和CT扫描仪市场中，双模态系统占据了重要份额，因为它们结合了PET和CT成像技术的优势。这种整合为临床医生提供了增强的诊断能力，从而改善患者的治疗效果。慢性疾病的日益普遍需要先进的成像技术，巩固了双模态在市场中的主导地位，而单模态系统则代表了一个具有特定应用和较低成本的增长细分市场。

模式：双重模式（主导）与单一模式（新兴）

双模态系统在PET和CT扫描仪市场中已得到广泛应用，吸引了寻求综合成像解决方案的医院和诊断中心。它们在一次会话中提供功能和解剖信息的能力使其高效且节省时间。相比之下，单模态系统虽然正在兴起，但专门针对特定成像应用，吸引需要专业服务或有预算限制的机构。随着医疗技术的进步和整合变得愈加重要，双模态系统的需求预计将增长，而单模态设备将在专注诊断中保持战略性角色。

### 按应用：肿瘤学（最大）与心脏病学（增长最快）

在PET和CT扫描仪市场中，各应用细分市场的份额各不相同。肿瘤学仍然是主导细分市场，受到癌症发病率上升和对早期检测方法重视程度提高的推动。相比之下，心脏病学正在迅速增长，受到心血管疾病发病率上升和成像技术进步的推动。

肿瘤学：主导 vs. 心脏病学：新兴

肿瘤学应用在PET和CT扫描设备中占据了重要的市场地位，这得益于癌症病例的持续增加以及对准确诊断影像的需求。该细分市场受益于持续的技术进步，增强了成像能力，使医疗专业人员能够有效地规划和评估治疗。相反，心脏病学细分市场正在强劲崛起，越来越多的医疗提供者采用PET和CT扫描进行心脏应用，这一趋势是由于对心脏病管理中精确诊断的需求。该细分市场的增长得到了混合成像和改善可及性等创新的支持，使其成为未来市场扩展的焦点。

### 由宠物追踪器：FDG（最大）与氟-18（增长最快）

在PET和CT扫描仪市场中，PET示踪剂的细分市场展现出明显的市场份额分布。其中，FDG（氟脱氧葡萄糖）因其在肿瘤检测和监测中的广泛应用而占据最大份额。紧随其后的是氟-18，以其有效性和在神经系统疾病中的日益采用而闻名。这些示踪剂的需求持续上升，展示了这一细分市场的竞争性，创新和临床应用推动了偏好。PET示踪剂领域的增长趋势表明，特别是氟-18被认为是增长最快的示踪剂，得益于放射化学和制造工艺的进步。随着医疗系统向个性化医疗转型，对碳-11和氮-13等多样化示踪剂的需求也在上升，进一步巩固了对PET扫描技术的需求。人口老龄化和慢性疾病的增加等因素正在推动整个细分市场的增长，导致对示踪剂技术的更多研究和开发。

FDG（主导）与氮-13（新兴）

FDG 是市场上主要的宠物示踪剂，因其在肿瘤成像中的有效性而广泛应用于临床和诊断领域。它作为 PET 成像协议中的标准参考点，在医疗提供者中享有良好的声誉。另一方面，氮-13 正在成为一种有前景的替代品，特别是在心脏成像和研究环境中。尽管使用频率仍低于 FDG，但它在动态成像过程和从组织中更快清除方面提供了独特的优势。随着技术进步使得更好的合成和应用成为可能，氮-13 的市场地位正在发展，吸引了寻求改善诊断选项的研究人员和临床医生的关注。

## Regional Market Share Analysis

PET和CT扫描仪市场预计将在未来几年显著增长，这主要受到伴侣动物普遍增加和对先进诊断影像技术需求上升的推动。区域市场细分提供了不同地区增长动态和机会的宝贵见解。

北美预计将在PET和CT扫描仪市场中占据主导地位，这得益于庞大的宠物人口、先进的医疗基础设施以及对先进医疗技术的高度采用。欧洲是另一个主要市场，原因在于宠物主人的可支配收入较高以及对宠物健康和福祉的日益关注。

亚太地区预计将在市场中见证显著增长，这主要是由于宠物人口迅速增长和对宠物医疗服务需求上升。南美以及中东和非洲也预计将对全球市场增长作出贡献，尽管增速较慢。

**来源：初步研究、二次研究、MRFR数据库和分析师评审**

## Competitive Benchmarking

在PET和CT扫描仪市场中，主要参与者专注于开发创新技术，以满足对先进兽医诊断成像解决方案日益增长的需求。领先的PET和CT扫描仪市场参与者正在投资于研究和开发，以增强其设备的能力并扩展其产品组合。PET和CT扫描仪市场的竞争非常激烈，主要参与者通过战略合作、收购和产品差异化争夺市场份额。

预计竞争格局在未来几年将保持动态，受到技术进步和对宠物医疗服务需求增加的推动。GE医疗是全球PET和CT扫描仪市场的领先参与者。该公司提供一系列PET和CT扫描仪，包括Discovery PET/CT和Revolution EVO PET/CT。GE医疗的PET和CT扫描仪以其高质量的成像能力和先进的功能而闻名，例如迭代重建算法和剂量减少技术。

该公司在全球范围内拥有强大的市场存在和广泛的分销网络，使其能够满足全球兽医和宠物主人的需求。西门子医疗是全球PET和CT扫描仪市场的另一个主要参与者。该公司提供一系列PET和CT扫描仪，包括Biograph mCT和Somatom Definition AS+。

西门子医疗的PET和CT扫描仪旨在为兽医提供准确和详细的图像，以诊断和治疗各种宠物健康状况。该公司高度重视创新，不断开发新技术以提高其PET和CT扫描仪的性能。西门子医疗在全球范围内拥有强大的市场存在和分销网络，使其能够接触到广泛的客户群。

## Recent News & Developments

- **2024年第二季度：西门子医疗推出Biograph Vision.X PET/CT扫描仪，具备扩展的数字化功能** 西门子医疗宣布推出其新款Biograph Vision.X PET/CT扫描仪，采用增强的数字检测技术和改进的工作流程自动化，旨在提高肿瘤学和神经学影像的诊断准确性和效率。
- **2024年第二季度：GE医疗获得Omni Legend PET/CT系统的FDA 510(k)批准** GE医疗宣布已获得FDA 510(k)批准，允许其Omni Legend PET/CT系统上市，该系统结合了先进的数字探测器技术和人工智能驱动的影像软件，以改善图像质量并缩短扫描时间。
- **2024年第一季度：飞利浦在ECR 2024上推出新款Vereos数字PET/CT** 飞利浦在2024年欧洲放射学大会上推出其最新的Vereos数字PET/CT扫描仪，强调全数字检测和工作流程的增强，旨在支持高容量的肿瘤学和心脏影像中心。
- **2024年第二季度：佳能医疗在欧洲推出Cartesion Prime数字PET/CT** 佳能医疗系统宣布在欧洲推出其Cartesion Prime数字PET/CT，具备全数字探测器和先进的重建算法，以提高病灶可检测性和患者通量。
- **2024年第一季度：联合影像医疗在德克萨斯州开设新的PET/CT制造设施** 联合影像医疗在德克萨斯州启用了一座新的制造设施，专注于PET/CT扫描仪的生产，旨在扩大其在北美市场的影响力并改善美国客户的交货时间。
- **2024年第二季度：西门子医疗与梅奥诊所宣布战略合作伙伴关系，以推进PET/CT影像研究** 西门子医疗与梅奥诊所建立了为期多年的合作伙伴关系，专注于开发下一代PET/CT影像协议和肿瘤学及神经学诊断的人工智能应用。
- **2024年第一季度：GE医疗与HCA医疗签署多年PET/CT供应协议** GE医疗宣布与HCA医疗签署了一项多年协议，向HCA医疗提供PET/CT扫描仪及相关影像解决方案，支持HCA在其医院网络中扩展先进的诊断影像服务。
- **2024年第二季度：飞利浦获得新款Spectral PET/CT系统的CE标志** 飞利浦获得新款Spectral PET/CT系统的CE标志批准，允许在欧盟内商业化，并扩大对肿瘤学和心脏病学应用的先进光谱影像的获取。
- **2024年第一季度：佳能医疗系统与牛津大学合作进行PET/CT影像研究** 佳能医疗系统宣布与牛津大学建立研究合作关系，开发新型PET/CT影像技术和放射性示踪剂，以实现早期疾病检测。
- **2024年第二季度：联合影像医疗获得2亿美元D轮融资，以扩展PET/CT研发** 联合影像医疗获得2亿美元D轮融资，以加速下一代PET/CT扫描仪的研发，并扩大其全球市场覆盖。
- **2024年第一季度：西门子医疗任命新分子影像部门负责人** 西门子医疗宣布任命安娜·穆勒博士为新任分子影像部门负责人，负责公司的PET/CT和SPECT/CT产品线。
- **2024年第二季度：GE医疗在芝加哥开设新的PET/CT创新中心** GE医疗在芝加哥开设了一座新的创新中心，专注于先进PET/CT影像技术和人工智能驱动的诊断工具的开发与测试。

## Report Scope

| 2024年市场规模 | 0.8654（十亿美元） |
| --- | --- |
| 2025年市场规模 | 0.9833（十亿美元） |
| 2035年市场规模 | 3.526（十亿美元） |
| 复合年增长率（CAGR） | 13.62%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 人工智能在影像分析中的整合提高了PET和CT扫描仪市场的诊断准确性。 |
| 关键市场动态 | 技术进步和监管变化推动PET和CT扫描仪市场的竞争动态。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 2035年PET和CT扫描仪市场的预计市场估值是多少？**
A: 预计到2035年，PET和CT扫描仪市场的市场估值为35.26亿美元。

**Q: 2024年PET和CT扫描仪市场的市场估值是多少？**
A: 2024年PET和CT扫描仪市场的市场估值为8.654亿美元。

**Q: 2025年至2035年，PET和CT扫描仪市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，PET和CT扫描仪设备市场的预期CAGR为13.62%。

**Q: 在PET和CT扫描仪市场中，哪些公司被视为关键参与者？**
A: PET和CT扫描仪市场的主要参与者包括西门子医疗、GE医疗、飞利浦医疗和佳能医疗系统。

**Q: PET和CT扫描仪的主要应用是什么？**
A: PET和CT扫描仪的主要应用包括肿瘤学、心脏病学、神经学及其他应用。

**Q: 2024年单一模式和双重模式的表现如何？**
A: 在2024年，单一模式细分市场的价值为5.188亿美元，而双重模式细分市场的价值为3.466亿美元。

**Q: 在PET和CT扫描仪市场中，肿瘤学应用的市场规模是多少？**
A: 2024年，PET和CT扫描仪市场中肿瘤应用的市场规模为3.45亿美元。

**Q: 到2035年，FDG和氟-18 PET示踪剂的预计值是多少？**
A: 到2035年，FDG和氟-18 PET示踪剂的预计值分别为14.26亿美元和8.95亿美元。

**Q: 神经学应用市场与心脏病学应用市场相比如何？**
A: 在2024年，神经学应用市场的价值为1.75亿美元，而心脏病学应用的价值为2.15亿美元。

**Q: PET和CT扫描仪市场的预期增长趋势是什么？**
A: PET和CT扫描仪市场似乎正处于增长趋势，预计从2024年的8.654亿美元增长到2035年的35.26亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/pet-ct-scanner-device-market-29389*